- Home
- ESLA vs TACT Comparison
ESLA vs TACT Comparison
Compare ESLA & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESLA | TACT |
|---|---|---|
| Founded | 2021 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.9M | 41.6M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | ESLA | TACT |
|---|---|---|
| Price | $1.04 | $3.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $8.00 | $5.00 |
| AVG Volume (30 Days) | ★ 81.5K | 52.7K |
| Earning Date | 02-26-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $50,258,000.00 |
| Revenue This Year | N/A | $21.67 |
| Revenue Next Year | N/A | $7.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 8.27 |
| 52 Week Low | $0.73 | $3.12 |
| 52 Week High | $3.15 | $5.70 |
Technical Indicators
Market Signals| Indicator | ESLA | TACT |
|---|---|---|
| Relative Strength Index (RSI) | 39.14 | 40.27 |
| Support Level | $0.90 | $3.53 |
| Resistance Level | $1.13 | $4.01 |
| Average True Range (ATR) | 0.14 | 0.27 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 22.79 | 8.86 |
Price Performance
Historical ComparisonAbout ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.